Surface Oncology Inc (NASDAQ:SURF)

4.29
Delayed Data
As of Jan 14
 -0.10 / -2.28%
Today’s Change
4.21
Today|||52-Week Range
14.40
-10.25%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Surface Oncology Inc have a median target of 17.00, with a high estimate of 18.00 and a low estimate of 14.00. The median estimate represents a +296.27% increase from the last price of 4.29.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Surface Oncology Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.08
Sales
$13.7M
Reporting Date
Mar 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 80.91%
 
 
 
 
 
 
Growthannually -185.88%
 
 
 
 
 
 

Sales

Growthquarterly 3,389.12%
 
 
 
 
 
 
Growthannually -87.15%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.